EMA publishes EPAR for Aerivio Spiromax

5 September 2016 - The EMA has published an EPAR for Teva Pharmaceuticals' version of GSK's Seretide/Advair. ...

Read more →

Bevespi Aerosphere approved by the US FDA for patients with COPD

22 April 2016 - AstraZeneca announced that the US FDA has approved Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) inhalation aerosol for ...

Read more →